{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:15:48Z","timestamp":1787170548321,"version":"build-2736575974"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01959","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:46:40Z","timestamp":1535417200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype"],"prefix":"10.3389","volume":"9","author":[{"given":"Mandy","family":"Sowa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Kolenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Baumgart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Pratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Tornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Suchanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Mytilinaiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Hammermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"Laass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Roggenbuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schierack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2015.08.016","article-title":"Using GWAS to identify genetic predisposition in hepatic autoimmunity","volume":"66","author":"Webb","year":"2016","journal-title":"J Autoimmun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2017.01.019","article-title":"Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis","volume":"66","author":"Vesterhus","year":"2017","journal-title":"J Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrgastro.2017.154","article-title":"Evaluation of indeterminate biliary strictures","volume":"14","author":"Bowlus","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/gutjnl-2016-311739","article-title":"Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis","volume":"66","author":"Jendrek","year":"2017","journal-title":"Gut"},{"key":"B8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41598-017-18622-1","article-title":"Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis","volume":"8","author":"Tornai","year":"2018","journal-title":"Sci Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-230X-9-58","article-title":"The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli Type 1 fimbriae","volume":"9","author":"Yu","year":"2009","journal-title":"BMC Gastroenterol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/gutjnl-2014-307854","article-title":"Species-specific and pathotype-specific binding of bacteria to zymogen granule membrane glycoprotein 2 (GP2)","volume":"64","author":"Schierack","year":"2015","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.4049\/jimmunol.1103190","article-title":"Identification of pancreatic Glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responses","volume":"189","author":"Werner","year":"2012","journal-title":"J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1515\/cclm-2013-0801","article-title":"Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challenges","volume":"52","author":"Roggenbuck","year":"2014","journal-title":"Clin Chem Lab Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1136\/gut.2008.162495","article-title":"Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease","volume":"58","author":"Roggenbuck","year":"2009","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.crohns.2012.10.011","article-title":"Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2","volume":"7","author":"Komorowski","year":"2013","journal-title":"J Crohns Colitis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature08529","article-title":"Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response","volume":"462","author":"Hase","year":"2009","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3389\/fimmu.2017.00942","article-title":"Interactions between intestinal microbiota and host immune response in inflammatory bowel disease","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fimmu.2016.00290","article-title":"Mucosal interactions between genetics, diet, and microbiome in inflammatory bowel disease","volume":"7","author":"Basson","year":"2016","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/bs.acc.2016.06.002","article-title":"Autoimmunity in crohn's disease-a putative stratification factor of the clinical phenotype","volume":"77","author":"Roggenbuck","year":"2016","journal-title":"Adv Clin Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1097\/MPG.0b013e318275fa77","article-title":"Glycoprotein 2 antibodies in inflammatory bowel disease - no association with disease phenotype?","volume":"56","author":"Roggenbuck","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"S368","DOI":"10.1016\/S0016-5085(17)31481-6","article-title":"The novel isoforms 1 and 4 of serum anti-GP2 antibody are linked to earlier surgical recurrence in Crohn's disease (CD) subjects after first surgery","volume":"152","author":"W\u00f6lfel","year":"2017","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e522","DOI":"10.1016\/j.crohns.2013.03.009","article-title":"Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch","volume":"7","author":"Werner","year":"2013","journal-title":"J Crohns Colitis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1097\/MIB.0000000000000936","article-title":"Serologic anti-GP2 antibodies are associated with genetic polymorphisms, fibrostenosis, and need for surgical resection in crohn's disease","volume":"22","author":"Degenhardt","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0167-4781(00)00057-9","article-title":"Molecular cloning and sequences of cDNAs encoding alpha (large) and beta (small) isoforms of human pancreatic zymogen granule membrane-associated protein GP2","volume":"1491","author":"Fukuoka","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1097\/MIB.0000000000001159","article-title":"Autoantibodies against GP2 isoforms in pediatric patients with Crohn's disease: differences in reactivity and correlation to clinical features","volume":"23","author":"R\u00f6ber","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cca.2015.01.018","article-title":"Autoreactivity to isoforms of glycoprotein 2 in inflammatory bowel disease","volume":"442","author":"Roggenbuck","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B27","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","article-title":"Diagnosis and classification of ulcerative colitis","volume":"13","author":"Conrad","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.autrev.2014.01.029","article-title":"Diagnosis and classification of Crohn's disease","volume":"13","author":"Laass","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e83924","DOI":"10.1371\/journal.pone.0083924","article-title":"Stable expression of human muscle-specific kinase in HEp-2 M4 cells for automatic immunofluorescence diagnostics of myasthenia gravis","volume":"9","author":"George","year":"2014","journal-title":"PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/ecco-jcc\/jjv087","article-title":"Rediscovery of the anti-pancreatic antibodies and evaluation of their prognostic value in a prospective clinical cohort of crohn's patients: the importance of specific target antigens [GP2 and CUZD1]","volume":"9","author":"Papp","year":"2015","journal-title":"J Crohns Colitis"},{"key":"B32","first-page":"1415","article-title":"Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis","volume":"22","author":"Wilschanski","year":"1995","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jhep.2013.04.018","article-title":"High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis","volume":"59","author":"Papp","year":"2013","journal-title":"J Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2016.10.003","article-title":"Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis","volume":"77","author":"Chung","year":"2017","journal-title":"J Autoimmun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e107743","DOI":"10.1371\/journal.pone.0107743","article-title":"Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA","volume":"9","author":"Sowa","year":"2014","journal-title":"PLoS ONE"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e112877","DOI":"10.1371\/journal.pone.0112877","article-title":"PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC)","volume":"9","author":"Stinton","year":"2014","journal-title":"PLoS ONE"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1038\/ctg.2018.1","article-title":"Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behcet's disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Clin Transl Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/hep.28128","article-title":"Risk stratification in autoimmune cholestatic liver diseases: opportunities for clinicians and trialists","volume":"63","author":"Trivedi","year":"2016","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/B978-0-12-407681-5.00006-4","article-title":"Glycoprotein 2 antibodies in Crohn's disease","volume":"60","author":"Roggenbuck","year":"2013","journal-title":"Adv Clin Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2016","journal-title":"Gut"},{"key":"B43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/gutjnl-2016-312180","article-title":"Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis","volume":"66","author":"Ruhlemann","year":"2017","journal-title":"Gut"},{"key":"B44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabibian","year":"2016","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jhep.2016.09.020","article-title":"The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation","volume":"66","author":"Schrumpf","year":"2017","journal-title":"J Hepatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MOG.","article-title":"Hepatobiliary disease in patients with cystic fibrosis","volume":"25","author":"Moyer","year":"2009","journal-title":"Curr Opin Gastroenterol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:46:42Z","timestamp":1535417202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2018.01959"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01959","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"article-number":"1959"}}